Pfizer beats quarterly estimates despite Covid product decline, reaffirms modest outlook - CNBC

Pfizer beats quarterly estimates despite Covid product decline, reaffirms modest outlook - CNBC
Business

Listen to this article

0%

Pfizer on Tuesday reported fourth-quarter results that topped estimates even amid dwindling demand for its Covid products, while reaffirming its modest 2026 guidance that rattled investors in Decembe… [+2938 chars]

Leave A Comment

Comments are moderated and may take time to appear.

Comments

No comments yet. Be the first to comment!

Stay Connected